Group One Trading
COLL icon

Group One Trading’s Collegium Pharmaceutical COLL Stock Holding History

Group One Trading’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$10.5K – 8256
2025
Q3 		$10.5K Sell
300
-200
-40% -$6.95K ﹤0.01% 7138
2025
Q2 		$14.8K Buy
+500
New +$14.3K ﹤0.01% 6460
2024
Q4 		– Sell
-5,200
Closed -$201K – 7361
2024
Q3 		$201K Hold
5,200
– – ﹤0.01% 3607
2024
Q2 		$167K Sell
5,200
-400
-7% -$13.9K ﹤0.01% 3548
2024
Q1 		$217K Buy
5,600
+2,600
+87% +$91K ﹤0.01% 3496
2023
Q4 		$92.3K Buy
3,000
+2,300
+329% +$57.6K ﹤0.01% 4534
2023
Q3 		$15.6K Buy
+700
New +$16K ﹤0.01% 6075
2023
Q2 		– Sell
-100
Closed -$2.4K – 7714
2023
Q1 		$2.4K Buy
+100
New +$2.65K ﹤0.01% 6569
2022
Q4 		– Sell
-3,000
Closed -$48K – 7335
2022
Q3 		$48K Buy
+3,000
New +$52.9K ﹤0.01% 5434
2021
Q2 		– Sell
-11,500
Closed -$273K – 8193
2021
Q1 		$273K Buy
+11,500
New +$273K ﹤0.01% 4689
2020
Q4 		– Sell
-5,100
Closed -$106K – 6554
2020
Q3 		$106K Buy
+5,100
New +$92.1K ﹤0.01% 4153
2019
Q3 		– Sell
-2,700
Closed -$36K – 5192
2019
Q2 		$36K Buy
2,700
+2,300
+575% +$30.8K ﹤0.01% 3937
2019
Q1 		$6K Sell
400
-11,000
-96% -$176K ﹤0.01% 4394
2018
Q4 		$196K Buy
11,400
+4,600
+68% +$78.7K ﹤0.01% 2700
2018
Q3 		$100K Buy
+6,800
New +$121K ﹤0.01% 3534
2018
Q2 		– Sell
-100
Closed -$3K – 5137
2018
Q1 		$3K Sell
100
-11,900
-99% -$284K ﹤0.01% 4584
2017
Q4 		$222K Buy
+12,000
New +$172K ﹤0.01% 2854
2017
Q2 		– Sell
-300
Closed -$3K – 4775
2017
Q1 		$3K Buy
+300
New +$4.46K ﹤0.01% 4383
2016
Q4 		– Sell
-3,000
Closed -$58K – 4458
2016
Q3 		$58K Buy
+3,000
New +$35.6K ﹤0.01% 3266

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Group One Trading's COLL Position: Q1 2026 in Review

Group One Trading sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 600 shares — an estimated $27.8K sold.

Group One Trading first reported a position in COLL in Q4 2016 and held it in 13 quarters. The position peaked at $945K in Q1 2023. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Group One Trading reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 600 Collegium Pharmaceutical shares in Q1 2026, an estimated $27.8K.
  • Group One Trading first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 13 quarters.
  • Group One Trading's Collegium Pharmaceutical position peaked at $945K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.